Home Markets Lilly expects orforglipron obesity results in third quarter Lilly expects orforglipron obesity results in third quarter Andrew M Jun 22, 2025 comments off Tweet on Twitter Share on Facebook Google+ Pinterest Original source: https://www.investing.com/news/stock-market-news/lilly-expects-orforglipron-obesity-results-in-third-quarter-4104658 Fluoroarenes GLP-1 receptor agonists Market Updates www.investing.com/news/stock-market-news/lilly-expects-orforglipron-obesity-results-in-third-quarter-4104658